5-AzaC Treatment Enhances Expression of Transforming Growth Factor-β Receptors through Down-regulation of Sp3
Open Access
- 1 August 2001
- journal article
- Published by Elsevier
- Vol. 276 (35) , 32854-32859
- https://doi.org/10.1074/jbc.m103951200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancerOncogene, 1999
- Induction of Transforming Growth Factor-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cells through SP1 Activation by 5-Aza-2′-deoxycytidinePublished by Elsevier ,1998
- Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-β receptor: regulation by TGF-βBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma CellsPublished by Elsevier ,1996
- Characterization of the Promoter Region of the Human Transforming Growth Factor-β Type II Receptor GeneJournal of Biological Chemistry, 1995
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Mechanism of activation of the TGF-β receptorNature, 1994
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990